During the past decade, Tulane University Heart and Vascular Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane University Heart and Vascular Institute" #1 collaborator was "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tulane University Heart and Vascular Institute" are "Coronary Artery Disease" (2 trials), "Heart Failure" (1 trials) and "Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)" (1 trials). Many other conditions were trialed in "Tulane University Heart and Vascular Institute" in a lesser frequency.

Most popular intervention types in "Tulane University Heart and Vascular Institute" are "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACE-I (lisinopril) or ARB (losartan)" (1 trials), "Aspirin" (1 trials), "Eplontersen" (1 trials), "FDC I/H" (1 trials) and "High dose potent statin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tulane University Heart and Vascular Institute" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tulane University Heart and Vascular Institute". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tulane University Heart and Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tulane University Heart and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".